The latest closing stock price for Supernus Pharmaceuticals as of March 31, 2025 is 32.75.
An investor who bought $1,000 worth of Supernus Pharmaceuticals stock at the IPO in 2012 would have $5,099 today, roughly 5 times their original investment - a 14.92% compound annual growth rate over 13 years.
The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
The Supernus Pharmaceuticals 52-week high stock price is 40.28, which is 23% above the current share price.
The Supernus Pharmaceuticals 52-week low stock price is 25.53, which is 22% below the current share price.
The average Supernus Pharmaceuticals stock price for the last 52 weeks is 32.68.
An investor who bought $1,000 worth of Supernus Pharmaceuticals stock at the IPO in 2012 would have $5,099 today, roughly 5 times their original investment - a 14.92% compound annual growth rate over 13 years.
The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
The Supernus Pharmaceuticals 52-week high stock price is 40.28, which is 23% above the current share price.
The Supernus Pharmaceuticals 52-week low stock price is 25.53, which is 22% below the current share price.
The average Supernus Pharmaceuticals stock price for the last 52 weeks is 32.68.